Allied Market Research

Male Infertility Market to Register a CAGR of 5% - Allied Market Research

The report forecasts the global male infertility market to stand at $301.5 million by 2020, with an expected CAGR of 5% during 2014-2020.


Portland, OR -- (ReleaseWire) -- 07/08/2014 --Allied Market Research publishes a report titled "Male Infertility Market (Techniques and Geography) - Global Industry Analysis, Size, Growth Trends, Share, Opportunities and Forecast 2012 – 2020."

The report forecasts the global male infertility market to stand at $301.5 million by 2020, with an expected CAGR of 5% during 2014-2020.

Major Infertility problems in males are due to low sperm count, presence of low motile sperm or azoospermia. Stress, consumption of alcohol or drugs, obesity, environmental toxins, smoking, etc., are the main reasons behind male infertility. These factors contribute towards the growth of male infertility market. The problem of infertility further intensifies in males due to stress, embarrassment and guilt. This is a major limitation of this market. Growing awareness among men and trending medical tourism would drive the market growth.

To View the Complete Report visit:

The report segments the market based on techniques, namely oxidative stress analysis, sperm agglutination test, DNA fragmentation, microscopic examination, computer assisted semen analysis, sperm penetration test, and others. As per the research, DNA fragmentation would generate maximum revenue by 2020.

The Geographical analysis of male infertility consists of North America, Europe, Asia Pacific and RoW. Due to increased awareness and adoption of advanced procedures in treating male infertility, North America is expected to dominate the global male infertility market during the estimated period. Asia Pacific and RoW would witness highest CAGR due to rising awareness about male infertility.
Similar Market Studies by Allied Market Research:

Global In Vitro Diagnostics (IVD) Market:

Neurovascular Market:

Some of the major companies analyzed by the report are ASKA Pharmaceutical Co. Ltd, ZydusCadila Healthcare Limited, Access Pharmaceuticals, Inc., Intas Pharmaceuticals Ltd., Pantarhei Bioscience B, Cordex Pharma, Inc., Merck Serono, Halotech DNA SL, SCSA diagnostics, Andrology Solutions.

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in capturing most accurate market data and confirms utmost accuracy of our market forecasts. Each and every data presented in the reports published by us is also extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Sona Padman
5320 SW Macadam Avenue,
Suite 100, Portland, OR 97239
United States
Direct: +1(617)674-4143
Toll Free: +1(855)711-1555 (U.S. & Canada)
Fax: +1(855)550-5975